Patent ID: 6855723

Claim:
An azabenzimidazole compound having a structure set forth in formula I: wherein, (a) R 1 , R 2 , and R 3 are independently selected from the group consisting of: (i) unsaturated alkyl; (ii) —NX 2 X 3 , where X 2 and X 3 are independently selected from the group consisting of hydrogen, saturated alkyl, unsaturated alkyl, homocyclic ring moieties, and heterocyclic ring moieties; (iii) halogen or trihalomethyl; (iv) a ketone of formula —CO—X 4 , where X 4 , is selected from the group consisting of hydrogen, alkyl, homocyclic ring moieties, and heterocyclic ring moieties; (v) a carboxylic arid of formula —(X 5 ) n —COOH or ester of formula —(X 6 ) n —COO—X 7 , wherein X 5 , X 6 , and X 7 , and are independently selected from the group consisting of alkyl, homocyclic ring moieties, and heterocyclic ring moieties, and wherein n is 0 or 1; (vi) an alcohol of formula (X 8 ) n —OH or an alkoxy moiety of formula —(X 8 ) n —O—X 9 , wherein X 8 and X 9 are independently selected from the group consisting of hydrogen, saturated alkyl, unsaturated alkyl, homocyclic ring moieties, and heterocyclic ring moieties, and wherein the ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, and ester, and wherein n is 0 or 1; (vii) an amide of formula —NHCOX 10 , wherein X 10 is selected from the group consisting of alkyl, hydroxyl, homocyclic ring moieties, and heterocyclic ring moieties, and wherein the ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, and ester; (viii) —SO 2 NX 11 X 12 , wherein X 11 and X 12 are selected from the group consisting of hydrogen, alkyl, and homocyclic ring moieties, and heterocyclic ring moieties; (ix) a homocyclic or heterocyclic ring moiety optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, and ester moieties; (x) an aldehyde of formula —CO—H; and (xi) a sulfone of formula —SO 2 —X 13 , where X 13 is selected from the group consisting of saturated alkyl, unsaturated alkyl, homocyclic ring moieties, and heterocyclic ring moieties; (b) Z 1 and Z 2 are NH; and (c) X 1 is independently selected from the group consisting of NH, sulfur, and oxygen.